Kratom Lawsuits in 2026: What Is Real, and What Is Being Misreported
Two things get repeated about kratom litigation that do not hold up: that there is a consolidated federal case, and that a court awarded $11 million in 2026. Neither is accurate. Here is what the record actually shows — including the federal action that did happen this year.
Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology
Reviewed by Leonard Goldberg, Editor · Last updated
What the Lawsuits Allege
Kratom is a plant-derived product sold in the United States as capsules, powders, extracts, shots and gummies. The lawsuits fall into two groups. Wrongful-death claims are brought by families of people who died with mitragynine — kratom's main alkaloid — identified in toxicology, often in cardiac-arrest cases. Addiction and deception claims allege that sellers marketed kratom as a safe, natural supplement while concealing its dependence potential. The legal theories are conventional product liability: strict liability, failure to warn, negligence, breach of warranty and fraud. Much of the recent concern centres not on the leaf but on 7-OH (7-hydroxymitragynine), a far more potent compound that is concentrated or synthesized into products many times stronger than traditional kratom.
Case Details
There is no kratom MDL. We checked the JPML's official census of pending multidistrict litigation dated August 3, 2026 — all 162 active MDL dockets — and kratom does not appear on it. Cases proceed individually in state and federal courts, with filings reported in Washington, Georgia, Florida, New York, Pennsylvania, Texas, California, Ohio, Colorado, Connecticut and New Mexico. No verified total case count exists, and we are not going to invent one. Separately, state attorneys general have taken action: Texas sued kratom retailers over products containing many times the state's legal 7-OH limit, and Missouri settled a suit in June 2026 that halted sales of concentrated 7-OH products.
Current Status — Verified August 22, 2026
Who Might Have a Claim
Two groups are bringing cases today: families in wrongful-death matters, where toxicology identified mitragynine and the death is attributed at least in part to kratom, and individuals alleging addiction or serious injury from products marketed without adequate warnings, particularly high-concentration 7-OH products. Because there is no MDL and no settlement, nobody is swept in automatically and there is nothing to register for. Whether a specific case is viable depends heavily on the product involved, the documentation (toxicology reports, medical records, purchase evidence with the product label) and the state's law — which varies enormously, since some states regulate or ban kratom outright and others do not.
The $11 Million Number — What It Actually Is
How This Developed
- 1
July 2023: The $11.6M default judgment
Talavera v. Grow, LLC (S.D. Fla.) — $11,642,895 entered as a default judgment after the defendant ceased defending. Widely recirculated in 2026 as if it were current.
- 2
2023: The first genuine kratom jury verdict
A Washington State jury returns $2.5 million in a wrongful-death case — the first kratom case actually tried to verdict in the United States.
- 3
July 2025: FDA moves against 7-OH products
The FDA issues warning letters to seven companies over illegal 7-OH products — tablets, gummies, drink mixes and liquid shots — and warns consumers about specific concentrated products.
- 4
March–June 2026: State attorneys general act
Missouri sues a major retailer and settles in June 2026, halting sales of concentrated 7-OH products. Texas sues retailers over products reportedly containing up to fifty times the state's legal 7-OH limit.
- 5
July 1–6, 2026: DEA moves to schedule 7-OH
The DEA announces intent to place 7-OH above a specified threshold into Schedule I; notices publish in the Federal Register on July 6. Natural leaf below the threshold is excluded. HHS and FDA publicly back the move.
- 6
What's next
Watch for the temporary scheduling order actually taking effect, for further state enforcement, and for whether the growing number of individual suits reaches the point of a consolidation petition. None of that exists today.
Misinformation and Scams in This Space
The gap between what people believe about kratom litigation and what the record shows is unusually wide — and some of it is being widened deliberately.
“$11 million awarded in 2026 — you could be next”
That judgment is from July 2023 and was entered by default, not by a jury. Presenting it as a current result is the single most common misrepresentation in this area. Ask any firm quoting it which case and which year they mean.
“Join the kratom class action”
There is no class action and no MDL — the JPML's August 3, 2026 census lists no kratom docket. Cases are individual. Nobody can add you to something that does not exist.
“Kratom is now illegal — claim compensation”
The DEA's action targets concentrated and synthetic 7-OH above a threshold, and expressly excludes natural leaf below it. A scheduling decision is also not a compensation programme — the two are unrelated.
Kratom Lawsuit FAQs
Is there a kratom class action or MDL?
No. We verified this against the JPML's official census of all 162 pending MDL dockets dated August 3, 2026 — kratom does not appear. Cases are individual lawsuits in state and federal courts, with no consolidation and no settlement programme.
Didn't a court award $11 million for a kratom death in 2026?
No. That figure is $11,642,895 from Talavera v. Grow, LLC, entered on July 27, 2023 in the Southern District of Florida — and it was a default judgment, entered after the defendant stopped defending, not a jury's verdict. It gets recirculated under 2026 headlines. The largest genuine jury verdict we could document is $2.5 million, also from 2023.
What is 7-OH and why does it matter more than kratom itself?
7-hydroxymitragynine is a minor alkaloid in the kratom leaf that is far more potent than the leaf's main compound. Products that concentrate or synthesize it can be dramatically stronger than traditional kratom, which is why both the FDA's enforcement and the DEA's scheduling action target 7-OH specifically rather than kratom generally.
Is kratom illegal now?
Not as a whole. The DEA's July 2026 action targets 7-OH above a specified threshold — 0.05% by dry weight, or 0.05%/1 mg per unit for extracts and concentrates — plus three related substances. Natural leaf below that threshold is expressly excluded. State law varies widely and independently, so legality depends on where you are and what the product contains.
My family member died and toxicology mentioned mitragynine. What now?
Preserve everything: the toxicology and autopsy reports, medical records, and any remaining product with its packaging and label — the label is often what identifies the seller and the concentration. Then speak to a product-liability attorney in your state. Because there is no MDL, these are individual cases and state law governs both the deadline and the standard of proof.
Are attorneys taking kratom cases?
Yes — a number of firms run active intake for kratom wrongful-death and addiction claims. That is a fact about the market, not an indication of how strong any individual case is. The absence of consolidation means each case stands on its own facts.
Why is there no MDL if there are cases everywhere?
Consolidation requires someone to petition the JPML and enough overlapping federal cases against common defendants to justify it. Kratom litigation is spread across many different sellers rather than a few large manufacturers, which makes centralization harder than in a typical pharmaceutical case.
Separate from this case: were you injured in the last 2 years?
Class-action payouts are fixed amounts through an administrator. A personal injury claim is a different case — and often worth far more. Free estimate, no obligation.